CYNTHIA BRADFORD: Open Payments
NPI 1417599044 · FORT MYERS, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,081 in 44 payments from 25 companies in 2025. Trend: 2023 $0 · 2024 $668 · 2025 $1,081
Food & beverage: $1,081
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. | 4 | $106 |
| Merck Sharp & Dohme LLC | 4 | $99 |
| Janssen Biotech, Inc. | 4 | $97 |
| AstraZeneca Pharmaceuticals LP | 3 | $73 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $72 |
| Blueprint Medicines Corporation | 2 | $67 |
| Incyte Corporation | 3 | $67 |
| SOBI, INC | 2 | $54 |
| Gilead Sciences, Inc. | 2 | $50 |
| E.R. Squibb & Sons, L.L.C. | 2 | $38 |
Products named: Enhertu, KEYTRUDA, AYVAKIT, CARVYKTI, Trodelvy, JAKAFI, ERLEADA, NINLARO.
Industry payments across FL — which companies pay providers there.
